Literature DB >> 25487721

4-D flow magnetic resonance imaging: blood flow quantification compared to 2-D phase-contrast magnetic resonance imaging and Doppler echocardiography.

Maya Gabbour1, Susanne Schnell, Kelly Jarvis, Joshua D Robinson, Michael Markl, Cynthia K Rigsby.   

Abstract

BACKGROUND: Doppler echocardiography (echo) is the reference standard for blood flow velocity analysis, and two-dimensional (2-D) phase-contrast magnetic resonance imaging (MRI) is considered the reference standard for quantitative blood flow assessment. However, both clinical standard-of-care techniques are limited by 2-D acquisitions and single-direction velocity encoding and may make them inadequate to assess the complex three-dimensional hemodynamics seen in congenital heart disease. Four-dimensional flow MRI (4-D flow) enables qualitative and quantitative analysis of complex blood flow in the heart and great arteries.
OBJECTIVES: The objectives of this study are to compare 4-D flow with 2-D phase-contrast MRI for quantification of aortic and pulmonary flow and to evaluate the advantage of 4-D flow-based volumetric flow analysis compared to 2-D phase-contrast MRI and echo for peak velocity assessment in children and young adults.
MATERIALS AND METHODS: Two-dimensional phase-contrast MRI of the aortic root, main pulmonary artery (MPA), and right and left pulmonary arteries (RPA, LPA) and 4-D flow with volumetric coverage of the aorta and pulmonary arteries were performed in 50 patients (mean age: 13.1 ± 6.4 years). Four-dimensional flow analyses included calculation of net flow and regurgitant fraction with 4-D flow analysis planes similarly positioned to 2-D planes. In addition, 4-D flow volumetric assessment of aortic root/ascending aorta and MPA peak velocities was performed and compared to 2-D phase-contrast MRI and echo.
RESULTS: Excellent correlation and agreement were found between 2-D phase-contrast MRI and 4-D flow for net flow (r = 0.97, P < 0.001) and excellent correlation with good agreement was found for regurgitant fraction (r = 0.88, P < 0.001) in all vessels. Two-dimensional phase-contrast MRI significantly underestimated aortic (P = 0.032) and MPA (P < 0.001) peak velocities compared to echo, while volumetric 4-D flow analysis resulted in higher (aortic: P = 0.001) or similar (MPA: P = 0.98) peak velocities relative to echo.
CONCLUSION: Excellent flow parameter agreement between 2-D phase-contrast MRI and 4-D flow and the improved volumetric 4-D flow velocity analysis relative to echo suggests that 4-D flow has the potential to become a clinical alternative to 2-D phase-contrast MRI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25487721      PMCID: PMC4450116          DOI: 10.1007/s00247-014-3246-z

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  34 in total

Review 1.  How we perform cardiovascular magnetic resonance flow assessment using phase-contrast velocity mapping.

Authors:  Ping Chai; Raad Mohiaddin
Journal:  J Cardiovasc Magn Reson       Date:  2005       Impact factor: 5.364

Review 2.  Applications of phase-contrast flow and velocity imaging in cardiovascular MRI.

Authors:  Peter D Gatehouse; Jennifer Keegan; Lindsey A Crowe; Sharmeen Masood; Raad H Mohiaddin; Karl-Friedrich Kreitner; David N Firmin
Journal:  Eur Radiol       Date:  2005-07-08       Impact factor: 5.315

3.  Encoding strategies for three-direction phase-contrast MR imaging of flow.

Authors:  N J Pelc; M A Bernstein; A Shimakawa; G H Glover
Journal:  J Magn Reson Imaging       Date:  1991 Jul-Aug       Impact factor: 4.813

4.  Parallel MRI with extended and averaged GRAPPA kernels (PEAK-GRAPPA): optimized spatiotemporal dynamic imaging.

Authors:  Bernd Jung; Peter Ullmann; Matthias Honal; Simon Bauer; Jürgen Hennig; Michael Markl
Journal:  J Magn Reson Imaging       Date:  2008-11       Impact factor: 4.813

5.  Cineangiography of the heart in a single breath hold with a segmented turboFLASH sequence.

Authors:  D J Atkinson; R R Edelman
Journal:  Radiology       Date:  1991-02       Impact factor: 11.105

Review 6.  Volatile anesthetics and cardiac function.

Authors:  Stefan G De Hert
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2006-03

Review 7.  Assessment of valve disease: qualitative and quantitative.

Authors:  Dominique Didier
Journal:  Magn Reson Imaging Clin N Am       Date:  2003-02       Impact factor: 2.266

8.  Magnetic resonance velocity mapping: clinical application of a new technique.

Authors:  S R Underwood; D N Firmin; R H Klipstein; R S Rees; D B Longmore
Journal:  Br Heart J       Date:  1987-05

9.  Four-dimensional flow assessment of pulmonary artery flow and wall shear stress in adult pulmonary arterial hypertension: results from two institutions.

Authors:  Alex J Barker; Alejandro Roldán-Alzate; Pegah Entezari; Sanjiv J Shah; Naomi C Chesler; Oliver Wieben; Michael Markl; Christopher J François
Journal:  Magn Reson Med       Date:  2014-06-27       Impact factor: 4.668

10.  Time-resolved 3D MR velocity mapping at 3T: improved navigator-gated assessment of vascular anatomy and blood flow.

Authors:  Michael Markl; Andreas Harloff; Thorsten A Bley; Maxim Zaitsev; Bernd Jung; Ernst Weigang; Mathias Langer; Jürgen Hennig; Alex Frydrychowicz
Journal:  J Magn Reson Imaging       Date:  2007-04       Impact factor: 4.813

View more
  24 in total

1.  4-D flow magnetic-resonance-imaging-derived energetic biomarkers are abnormal in children with repaired tetralogy of Fallot and associated with disease severity.

Authors:  Joshua D Robinson; Michael J Rose; Maria Joh; Kelly Jarvis; Susanne Schnell; Alex J Barker; Cynthia K Rigsby; Michael Markl
Journal:  Pediatr Radiol       Date:  2018-12-01

Review 2.  Gadolinium-based contrast agents in pediatric magnetic resonance imaging.

Authors:  Eric M Gale; Peter Caravan; Anil G Rao; Robert J McDonald; Matthew Winfeld; Robert J Fleck; Michael S Gee
Journal:  Pediatr Radiol       Date:  2017-04-13

3.  Measurement of cardiac valve and aortic blood flow velocities in stroke patients: a comparison of 4D flow MRI and echocardiography.

Authors:  Thomas Wehrum; Felix Guenther; Alexander Fuchs; Florian Schuchardt; Anja Hennemuth; Andreas Harloff
Journal:  Int J Cardiovasc Imaging       Date:  2018-01-11       Impact factor: 2.357

4.  Comparison of Prospective and Retrospective Gated 4D Flow Cardiac MR Image Acquisitions in the Carotid Bifurcation.

Authors:  Elliott R Hurd; Mengjiao Han; Jason K Mendes; J Rock Hadley; Chris R Johnson; Edward V R DiBella; John N Oshinski; Lucas H Timmins
Journal:  Cardiovasc Eng Technol       Date:  2022-05-26       Impact factor: 2.495

5.  Efficient method for volumetric assessment of peak blood flow velocity using 4D flow MRI.

Authors:  Michael J Rose; Kelly Jarvis; Varun Chowdhary; Alex J Barker; Bradley D Allen; Joshua D Robinson; Michael Markl; Cynthia K Rigsby; Susanne Schnell
Journal:  J Magn Reson Imaging       Date:  2016-05-18       Impact factor: 4.813

6.  4D flow MR imaging of the portal venous system: a feasibility study in children.

Authors:  Keyur Parekh; Michael Markl; Michael Rose; Susanne Schnell; Andrada Popescu; Cynthia K Rigsby
Journal:  Eur Radiol       Date:  2016-05-18       Impact factor: 5.315

Review 7.  4D flow MRI applications in congenital heart disease.

Authors:  Judy Rizk
Journal:  Eur Radiol       Date:  2020-09-01       Impact factor: 5.315

Review 8.  Advanced flow MRI: emerging techniques and applications.

Authors:  M Markl; S Schnell; C Wu; E Bollache; K Jarvis; A J Barker; J D Robinson; C K Rigsby
Journal:  Clin Radiol       Date:  2016-03-02       Impact factor: 2.350

9.  4D Flow MRI Quantification of Congenital Shunts: Comparison to Invasive Catheterization.

Authors:  Michael J Horowitz; Daniel F Kupsky; Howaida G El-Said; Laith Alshawabkeh; Seth J Kligerman; Albert Hsiao
Journal:  Radiol Cardiothorac Imaging       Date:  2021-04-01

Review 10.  Advanced cardiovascular multimodal imaging and aortic stenosis.

Authors:  Carmen Cionca; Alexandru Zlibut; Lucia Agoston-Coldea; Teodora Mocan
Journal:  Heart Fail Rev       Date:  2021-07-19       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.